申请人:Krueger Martin
公开号:US20050261343A1
公开(公告)日:2005-11-24
Substituted anthranilamides and use thereof as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis as well as their intermediate products for the production of anthranilamides are described.
本文描述了替代的蒽酰胺类化合物及其用作治疗由持续血管生成引起的疾病的药物代理,以及用于生产蒽酰胺类化合物的中间产物。